Siemens/Fuji
This article was originally published in The Gray Sheet
Executive Summary
Long-term supply agreement allows Siemens to offer Fuji's computed radiography (CR) systems with its full-field digital mammography (FFDM) technology. "Our strategic decision for a CR-based FFDM solution was driven by our determination that flat detector technology still has to mature for mammography applications," Frank Anton, MD president, special systems division, Siemens Medical Engineering Group stated in a Nov. 28 release. Fuji CR will be offered internationally with FFDM, which is installed as an upgrade to Siemens' Mammomat 3000 and 3000 Nova instruments. GE Medical Systems' Senographe 2000, based on flat detector technology, is the only digital mammography system currently available in the U.S. (1see related story, p. 5)
You may also be interested in...
Fischer Taking Chance With SenoScan 510(k), Leaving PMA Route Open
Fischer Imaging's premarket notification submission for the SenoScan full-field digital mammography system is readily convertible into a PMA, should FDA reject the 510(k) approach for the device, as the agency has done in the past.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.